1 |
Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA 2009;301:1909-19.
DOI
|
2 |
Rooke TW, Hirsch AT, Misra S, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:1555-70.
DOI
|
3 |
Ko YG, Ahn CM, Min PK, et al. Baseline characteristics of a retrospective patient cohort in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) registry. Korean Circ J 2017;47:469-76.
DOI
|
4 |
Kim HO, Kim JM, Woo JS, et al. Effects of chronic kidney disease on clinical outcomes in patients with peripheral artery disease undergoing endovascular treatment: analysis from the K-VIS ELLA registry. Int J Cardiol 2018;262:32-7.
DOI
|
5 |
Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-9.
DOI
|
6 |
Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24.
DOI
|
7 |
Rha SW, Choi SH, Kim DI, et al. Medical resource consumption and quality of life in peripheral arterial disease in Korea: PAD Outcomes (PADO) research. Korean Circ J 2018;48:813-25.
DOI
|
8 |
Writing Committee MembersGerhard-Herman MD, Gornik HL, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Vasc Med 2017;22:NP1-43.
DOI
|
9 |
Issa SM, Hoeks SE, Scholte op Reimer WJ, et al. Health-related quality of life predicts long-term survival in patients with peripheral artery disease. Vasc Med 2010;15:163-9.
DOI
|